PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma

被引：0
|
作者：
B Paiva
A Azpilikueta
N Puig
E M Ocio
R Sharma
B O Oyajobi
S Labiano
L San-Segundo
A Rodriguez
I Aires-Mejia
I Rodriguez
F Escalante
A G de Coca
A Barez
J F San Miguel
I Melero
机构：
[1] Clinica Universidad de Navarra,
[2] Centro de Investigaciones Medicas Aplicadas (CIMA),undefined
[3] Instituto de Investigación Sanitaria de Navarra (IDISNA),undefined
[4] Hospital Universitario de Salamanca,undefined
[5] IBSAL,undefined
[6] IBMCC (USAL-CSIC),undefined
[7] University of Texas Health Science Center at San Antonio,undefined
[8] Complejo Hospitalario de Leon,undefined
[9] Hospital Clinico Universitario de Valladolid,undefined
[10] Hospital Nuestra Señora de Sonsoles,undefined
来源：
Leukemia | 2015年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2110 / 2113
页数：3
相关论文
共 50 条
  • [1] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    Paiva, B.
    Azpilikueta, A.
    Puig, N.
    Ocio, E. M.
    Sharma, R.
    Oyajobi, B. O.
    Labiano, S.
    San-Segundo, L.
    Rodriguez, A.
    Aires-Mejia, I.
    Rodriguez, I.
    Escalante, F.
    de Coca, A. G.
    Barez, A.
    San Miguel, J. F.
    Melero, I.
    [J]. LEUKEMIA, 2015, 29 (10) : 2110 - 2113
  • [2] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    [J]. ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [3] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [4] Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
    Jelinek, Tomas
    Paiva, Bruno
    Hajek, Roman
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] The PD-1: PD-L1 pathway in the context of the osteosarcoma tumor microenvironment
    Koirala, Pratistha
    Gill, Jonathan
    Roth, Michael
    Piperdi, Sajida
    Park, Amy
    Poon, Vincent
    Fremed, Michael
    Hoang, Bang
    Gorlick, Richard
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Toxicities Associated With PD-1/PD-L1 Blockade
    Wang, Daniel Y.
    Johnson, Douglas B.
    Davis, Elizabeth J.
    [J]. CANCER JOURNAL, 2018, 24 (01): : 36 - 40
  • [7] PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Lote, Hazel
    Cafferkey, Catherine
    Chau, Ian
    [J]. CANCER TREATMENT REVIEWS, 2015, 41 (10) : 893 - 903
  • [8] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    [J]. CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [9] PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
    Jelinek, T.
    Hajek, R.
    [J]. ONCOIMMUNOLOGY, 2016, 5 (12):
  • [10] PD-1/PD-L1 Blockade After Transient Lymphodepletion to Treat Myeloma
    Kearl, Tyce
    Jing, Weiqing
    Johnson, Bryon D.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 730 - 731
12345